Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Bachleda currently holds 11,000 shares of Galera Therapeutics, Inc. (GRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Bachleda has been a net buyer of GRTX stock. They have purchased $24.8K and sold $0 worth of shares.
Mark Bachleda's most recent insider trade was on Mar 16, 2023, when they purchased 11,000 shares at $2.25 per share.
Mark Bachleda serves as Executive at Galera Therapeutics, Inc. (GRTX). They have executed 1 insider transactions totaling $24.8K over their tenure at the company.
Mark Bachleda holds the position of Executive at Galera Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Mark Bachleda has shown a buying trading pattern, with $24.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Mark Bachleda was on Mar 16, 2023, when they purchased $24.8K worth of GRTX shares. This transaction involved 11,000 shares at $2.25 per share.
Mark Bachleda currently owns 11,000 shares of Galera Therapeutics, Inc. (GRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Bachleda's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Bachleda has 1 Form 4 filings on record as an insider at Galera Therapeutics, Inc..
Set alerts for Mark Bachleda and 40,000+ other insiders.